Assort Health Review 2026: Pricing, EHR Depth & Alternatives

Assort Health is a US healthcare voice AI company that answers inbound patient calls for specialty practices and health systems. Its agents handle appointment scheduling, intake, referrals, eligibility checks, medication refills and payments, and they write back into the practice's EHR rather than into a separate inbox. The distinguishing choice is that Assort sells specialty by specialty, with different agent behaviour for orthopedics, dermatology, ophthalmology, cardiology and roughly a dozen other lines, instead of shipping one generic receptionist and asking the practice to configure it.

Is Assort Health a real company or a wrapper? It is well capitalised and growing fast. It raised a $120 million Series C led by Menlo Ventures at a $1.2 billion valuation on 25 June 2026, bringing total funding to $222 million. Does Assort Health publish pricing? No. There is no price card, no self-serve tier and no public demo line. Who is it wrong for? Single-site clinics outside the United States, anyone who needs a receptionist in a language Assort does not staff, and anyone whose real problem is calls going out to insurers rather than calls coming in from patients.

Published 26 August 2026. Last updated 26 August 2026. All competitor figures were checked against the linked sources on that date.

Hear a comparable agent before you book any sales call: dial +1 (218) 636-0234 (Jessica, US demo) or +370 5 200 2605 (Lithuanian demo). No signup. Then book a call when you want to scope your own deployment.

What Is Assort Health?

Assort Health was founded in 2023 by Jon Wang and Jeffery Liu, who are now co-CEOs. The first product was a voice agent for inbound patient phone calls at specialty practices. By the 2026 Series C the company described itself in broader terms: an agent platform spanning scheduling, intake forms, referrals, document processing, medication refills, eligibility verification, lab requests and payments, organised into named products (Concierge for inbound, Activate for outbound outreach, Orchestrate for visit operations, Empower as a staff copilot).

The funding history is worth reading as a signal about scope creep. In April 2025 the company had raised $26 million in total and described itself as a specialty-specific platform for managing patient phone calls. Fourteen months later it had raised $222 million and described itself as an operating system for the patient journey. That is normal for a company at this stage, and it is also the thing to probe in a demo: ask which modules are in general availability at practices your size, and which are early.

Assort's stated customers skew to specialty groups and, more recently, health systems. Independent coverage of the Series C names John Muir Health, Boston Bone and Joint Institute and MDCS Dermatology, and reports 20x revenue growth over 15 months. The company has also appointed a first chief medical officer, per its own press page (announcement dated 4 August 2026), which is a reasonable maturity marker for a vendor selling into clinical operations.

How Much Does Assort Health Cost?

Assort Health does not publish list pricing. There is no pricing page, no per-minute rate and no free tier anywhere on assorthealth.com as of 26 August 2026. That is the norm for this category and it follows from the sales motion: scope is set by call volume, number of locations, which specialties you run, how deep the EHR write-back goes, and a security review.

What you can do is control how the quote is built. Three questions change the number materially:

• Is the unit a call, a minute, a location, or a provider? Assort has publicly framed value in per-provider revenue terms, so expect provider-count to appear somewhere in the model. Per-provider pricing is predictable but punishes practices with many low-volume providers.
• What is billed when the agent fails? A call that transfers to a human in the first ten seconds is not the same product as a call the agent completes. Ask whether both are billed identically.
• What does the second specialty cost? The specialty-specific model is the differentiator, so find out whether adding orthopedics on top of dermatology is a configuration change or a new line item.

For a structural view of how any of these quotes compares with the alternative you already own, our breakdown of AI receptionist cost versus in-house staff sets out the per-hour arithmetic without vendor framing.

What Does "Specialty-Specific" Actually Mean?

This is the claim worth testing, because "specialty-specific" can mean anything from a different greeting to genuinely different triage logic.

Assort's own site lists agents for orthopedics, dermatology, ophthalmology, women's health, pediatrics, primary care, ENT and allergy, pain management, cardiology, urology, neurology, gastroenterology, podiatry, behavioral health, radiology, oncology and emergency medicine (assorthealth.com, verified 26 August 2026). The substance behind that list, per the Series C announcement, is a dataset of 190 million patient voice interactions, 62,000 care protocols and 1.6 million decision pathways.

Why it matters operationally: a caller who says "my knee gave out on the stairs" needs a different next question in an orthopedic practice than in primary care, and the appointment type, provider match and visit length all follow from that question. A generic agent asks the practice to encode this. A specialty agent claims to arrive with it. That is a real difference in time to value, and it is also the single thing to verify in a pilot rather than accept on slides.

How Deep Is the EHR Integration?

Assort states deep integration across 15 or more platforms without listing them all publicly. Independent Series C coverage names Epic and athenahealth specifically, which are the two that matter most for the US specialty and health-system buyer.

Integration depth is where healthcare voice AI is genuinely hard, and it is where most vendor comparisons go vague. There are three tiers, and the difference between them is most of the product:

• Read-only. The agent can see availability and provider directories. It tells the patient what is free and then leaves a task for a human to book. Useful, but the human queue is still the bottleneck.
• Write-back. The agent books, reschedules and cancels directly in the scheduling system, respecting appointment types, provider rules and new-patient slot logic. This is where staff time is actually recovered.
• Full workflow. Intake, insurance eligibility, referral documents and refill requests all land in the right place in the chart. This is what Assort is selling at Series C, and it is the tier where a failed write is a clinical-operations incident rather than an inconvenience.

Ask which tier applies to your EHR instance, not to the product in general. A vendor can be tier three on Epic and tier one on your practice-management system. If you are on a dental or specialty PMS rather than a major EHR, our integration guides for Eaglesoft and Cloud9 show what tier-three write-back looks like in practice.

Where Does Assort Health Fall Short?

Four limits, stated plainly.

1. Opacity on price and product. No published pricing and no public demo line means you cannot evaluate voice quality or cost before entering a sales process. Some vendors publish a number you can call. Assort does not, as of 26 August 2026.

2. Metrics are self-reported and drawn from named best cases. The Series C release cites a 5% appointment volume lift, a 115% increase in labor capacity and a 4.3/5 patient satisfaction score; the company's site attributes the biggest hold-time results to specific practices, including an 81% decrease in abandonment rate at Peninsula Orthopaedic. These are plausible and they are also the outcomes the vendor chose to publish. Ask for the median across deployments and the range, not the showcase.

3. It is a young company selling into slow-moving buyers. Founded 2023, first product 2024, now selling to health systems. That is fast, and fast in health IT means a lot of the deployment playbook is being written while you are in it.

4. US-first by design. Everything about the product, from the specialty taxonomy to the eligibility checks to the payments module, is shaped by US healthcare. That is a strength in Ohio and a mismatch in Vilnius or Amsterdam.

Assort vs Hippocratic AI vs Infinitus: Three Different Jobs

These three names appear together in "healthcare voice AI" roundups constantly, and treating them as substitutes is the most common mistake buyers make in this category. They talk to different people, for different reasons, on behalf of different budget holders.

Read the table by the second column. If your problem is that patients cannot get through on the phone, Assort and Hyro are in scope and Infinitus is not. If your problem is that your staff spend their afternoons on hold with insurers, the reverse is true, and our Infinitus review covers that case. If your problem is that discharged patients are not being followed up, neither is the right tool and the Hippocratic AI review is the relevant one.

Assort Health vs Hyro vs AInora vs PolyAI

Narrowing to the vendors that genuinely compete for the same inbound patient-access budget:

Where AInora is genuinely weaker: we do not have Assort's specialty voice dataset, we do not ship a pre-built Epic integration, and we are not the vendor a US health system with a 300-seat contact centre should shortlist first. Where we are a better fit is narrow and specific: a clinic or group inside the EU that needs GDPR-aligned data handling and EU deployment, needs the agent to work in Lithuanian, Latvian, Estonian, Polish or several of those at once, and wants the deployment run for them rather than handed over as a builder. Our PolyAI review and Hyro comparison apply the same standard to those two.

Who Should Not Buy Assort Health?

A single-location practice with two providers. The procurement overhead and the integration scope are built for groups. You will get more value faster from an SMB-scoped receptionist, and our medical clinic and mental health pages describe what that looks like.

Anyone outside the United States. There is no published EU data residency posture, no published EU language coverage, and the eligibility and payments modules assume US payers. A European buyer should start from GDPR requirements for voice agents and work backwards to a vendor, not the other way round.

Anyone whose bottleneck is outbound. If the pain is prior authorisation follow-ups, insurer hold times or benefit verification, this is the wrong category entirely.

Anyone who needs to hear it first. If you cannot start a procurement cycle without hearing the agent, note that Assort does not publish a number to call. That is a legitimate reason to test a vendor that does before you commit calendar time.

Which Assort Health Alternatives Are Worth Shortlisting?

• Hyro. The closest direct comparator for US health systems, with a longer track record and Epic, Cerner and athenahealth integration. Better fit if you are a large system rather than a specialty group.
• AInora. The EU-side answer: multilingual including Lithuanian and the Baltics, EU deployment, managed rather than DIY, and live demo numbers you can call today. Not the choice for US EHR depth.
• PolyAI. Enterprise voice AI across industries. Stronger if healthcare is one of several call types you are consolidating.
• Practice-management-native options. If your scheduling lives in a specialist system, a vendor built around it can beat a generalist. See our reviews of SimplePractice, Jane App and Kareo/Tebra.
• Dental and DSO-specific vendors. Dental scheduling logic is different enough to warrant its own category: start with AI receptionists for dental groups and DSOs.

How Should a European Clinic Evaluate Assort Health?

Briefly, and probably not for long. Three checks decide it.

Data residency. Ask where call audio, transcripts and any patient identifiers are processed and stored, and whether an EU-only path exists. Voice recordings of patients are health data under GDPR, which raises the bar above ordinary customer-service processing. Our EU data residency comparison sets out what an acceptable answer looks like.

Language. Assort does not publish non-English coverage. If your patients call in Lithuanian, Latvian, Polish or a mix, this is decided before any feature discussion. See multilingual voice agents for Baltic businesses and multilingual voice agents.

AI Act transparency. An EU deployment has to tell the caller they are speaking to an AI system, and that disclosure has to be in the flow rather than in a policy document. Our note on EU AI Act transparency requirements for AI callers covers the practical wording.

For context on why every developed health system is buying something in this category: US federal workforce data as of 30 June 2026 records 9,003 designated Primary Medical Health Professional Shortage Areas covering 108,566,500 people, with 47.43% of need met and 18,541 additional practitioners required to lift those designations (HRSA, Bureau of Health Workforce). Voice AI does not add clinical capacity. It protects the capacity that exists from being consumed by scheduling questions, which is a smaller claim and a more defensible one. The same logic drives adoption across dental and Nordic healthcare markets.

Frequently Asked Questions